Suven Life Sciences Ltd share price logo

Suven Life Sciences Share Price

NSE: SUVEN

BSE: 530239

Small Cap

Healthcare Sector

₹134.07

-3.80

(-2.76%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Suven Life Sciences Stock Performance

as on January 23, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹132.11
    ₹138.69
    downward going graph

    1.46%

    Downside

    3.45%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹102.50
    ₹299.99
    downward going graph

    23.55%

    Downside

    123.76%

    Upside

    downward going graph

Suven Life Sciences share price movements today

Previous Close
₹137.87
Open
₹137.87
Volume
2.48L
Upper Circuit
₹165.44
Lower Circuit
₹110.30
Day's Low - High
₹132.11 - ₹138.69
52 Week Low - High
₹102.50 - ₹299.99

Suven Life Sciences Historical Returns

1 Month Return
-20.01 %
3 Month Return
-32.85 %
1 Year Return
+ 10.74 %
3 Year Return
+ 112.14 %
5 Year Return
+ 75.48 %

Suven Life Sciences Fundamentals

as on January 23, 2026 at 4:01 pm IST

Market Cap

₹3,049.75 Cr

Return on Equity (ROE)

-6.33

PE Ratio (TTM)

-13.89

Return on capital employed (ROCE)

-6.3

Industry PE ratio

46.27

Beta (LTM)

1.01

P/B Ratio

3.09

Dividend Yield

0

PEG Ratio

4.71

Quarterly Earnings Growth YOY

55.74

EPS (TTM)

-7.37

Sector

Healthcare

Book Value

5.04

Technical Analysis

Bearish

View Technical Analysis

Suven Life Sciences Stock Valuation

as on January 23, 2026 at 4:01 pm IST

Suven Life Sciences in the last 5 years

  • Overview

  • Trends

Lowest (-165.11x)

February 27, 2020

Today (-13.89x)

January 23, 2026

Industry (46.27x)

January 23, 2026

Highest (-6.67x)

March 27, 2023

LowHigh

Today’s Price to Earnings Ratio: -13.89x

Suven Life Sciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Suven Life Sciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Suven Life Sciences Ltd image
Suven Life Sciences Ltd
NA3,049.7515.1%0.51-1616
Vijaya Diagnostic Centre Ltd image
Vijaya Diagnostic Centre Ltd
BUY10,251.6012.13%0.65143704
Shree Pacetronix Ltd image
Shree Pacetronix Ltd
NA56.88260.18%0.64316
Syngene International Ltd image
Syngene International Ltd
BUY21,911.85-1.44%0.584963,642
Aspira Pathlab & Diagnostics Ltd image
Aspira Pathlab & Diagnostics Ltd
NA66.5928.37%0.58222
See all

Suven Life Sciences Share Price Target

Get share price movements and forecasts by analysts on Suven Life Sciences.

Source: S&P Global Market Intelligence

Suven Life Sciences Stock’s Investor Sentiment and Interest

Search interest for Suven Life Sciences Ltd Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:10% versus previous 30 day period

Suven Life Sciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
2.61
3.8
3.06
2.45
2.39
1.01
2.57
1.61
1.47
1.87
0.92
Other Income
5.6
5.64
12.6
6.07
4.28
4.01
4.04
1.63
1.22
0.6
3.78
Total Income
8.21
9.44
15.66
8.52
6.67
5.01
6.61
3.24
2.69
2.47
4.7
Expenses
34.13
31.81
26.57
48.64
32.67
31.54
54.78
40.82
45.29
52.62
80.69
Operating Profit
-31.52
-28.01
-23.51
-46.19
-30.28
-30.53
-52.21
-39.21
-43.82
-50.75
-79.77
Operating Profit Margin %
-1207.66%
-737.11%
-768.3%
-1885.31%
-1266.95%
-3022.77%
-2031.52%
-2435.4%
-2980.95%
-2713.9%
-8670.65%
Profit Before Interest, Tax and Depreciation
-25.92
-22.37
-10.91
-40.13
-26
-26.53
-48.17
-37.58
-42.6
-50.15
-75.99
Interest
0.05
0.05
0.04
0.04
0.03
0.02
0.02
0.01
-
-
-
Depreciation
1.67
1.66
1.73
1.6
1.51
1.49
1.46
1.53
1.35
1.37
1.32
Profit Before Tax
-27.64
-24.08
-12.68
-41.77
-27.54
-28.04
-49.65
-39.12
-43.95
-51.52
-77.31
Tax Paid
-
-
-
-
-1
-
-
-
-
-
-
Profit After Tax
-27.64
-24.09
-12.68
-41.76
-26.54
-28.04
-49.64
-39.12
-43.94
-51.52
-77.31
Total Net profit including share of profit / Loss from associate company
-27.64
-24.09
-12.68
-41.76
-26.54
-28.04
-49.64
-39.12
-43.94
-51.52
-77.31
EPS
-1.17
-1.1
-0.58
-1.92
-1.22
-1.29
-2.27
-1.79
-2.02
-2.36
-3.48
Actual EPS
-1.17
-1.1
-0.58
-1.92
-1.22
-1.29
-2.27
-1.79
-2.02
-2.36
-3.48
Adjusted EPS
-1.17
-1.1
-0.58
-1.92
-1.22
-1.29
-2.27
-1.79
-2.02
-2.36
-3.48
Diluted EPS
-1.17
-1.1
-0.58
-1.92
-1.22
-1.29
-2.27
-1.79
-2.02
-2.36
-3.48

Suven Life Sciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
539.17
625.26
285.67
14.41
13.48
11.84
13.54
11.69
6.66
Other Income
21.09
23.27
27.25
14.04
7.75
5.32
14.45
28.59
10.9
Total Income
565.57
648.53
312.91
28.45
21.23
17.16
27.99
40.28
17.55
Expenses
415.4
427.07
300.06
130.2
93.54
134.23
139.42
139.7
172.43
Operating Profit
123.77
198.19
-14.39
-115.79
-80.06
-122.39
-125.88
-128.01
-165.77
Operating Profit Margin %
22.96%
31.7%
-5.04%
-803.54%
-593.92%
-1033.7%
-929.69%
-1095.04%
-2489.04%
Profit Before Interest, Tax and Depreciation
150.17
221.46
12.86
-101.75
-72.31
-117.07
-111.44
-99.42
-154.88
Interest
5.68
4.63
1.91
0.49
0.82
0.53
0.29
0.16
0.05
Depreciation
21.41
21.31
10.79
4.17
4.35
4.39
6.54
6.5
5.82
Profit Before Tax
123.08
195.52
0.16
-106.41
-77.48
-121.99
-118.27
-106.08
-160.75
Tax Paid
35.88
71.83
24.06
-12.18
-5.32
-
-
-1
-
Profit After Tax
87.19
123.69
-23.9
-94.22
-72.15
-122
-118.27
-105.08
-160.75
Total Net profit including share of profit / Loss from associate company
87.19
123.69
-23.9
-94.22
-72.15
-122
-118.27
-105.08
-160.75
EPS
6.84
9.72
-1.88
-7.4
-5.67
-9.05
-6.63
-4.82
-7.37
Actual EPS
6.84
9.72
-1.88
-7.4
-5.67
-9.05
-6.63
-4.82
-7.37
Adjusted EPS
0.32
0.45
-0.09
-6.82
-5.22
-8.34
-6.63
-4.82
-7.37
Diluted EPS
6.84
9.72
-1.88
-7.4
-5.67
-9.05
-6.63
-4.82
-7.37

Suven Life Sciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
67.5
109.17
69.94
-52.61
-134.57
-96.02
-127.54
-115.98
-115.47
-154.1
Cash Flow from Investing Activities
-38.63
-310.64
-0.61
30.43
146.21
55.85
-22.22
-247.81
94.44
154.95
Cash Flow from Financing Activities
-68.07
-30.39
-52.07
4.54
2.8
34.85
145.69
395.54
-1.06
-0.76
Net Cash Flow
-39.2
-231.86
17.26
-17.66
14.45
-5.33
-4.07
31.75
-22.09
0.09

Suven Life Sciences Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Jul 2025
Sep 2025
Dec 2025
Promoters
69.57%
69.57%
69.57%
69.57%
69.57%
70.27%
70.27%
70.27%
70.27%
70.27%
67.43%
67.36%
67.36%
DII
0.11%
0.08%
0.01%
0.12%
1.17%
1.17%
1.05%
1.06%
0.01%
0.02%
3.41%
3.39%
3.39%
FII
0%
0%
0.5%
0.54%
0.46%
0.45%
0.34%
0.34%
0.25%
0.59%
0.56%
1.18%
1.07%
Public
29.81%
29.88%
29.93%
29.77%
28.81%
28.12%
28.34%
28.34%
29.47%
29.12%
28.61%
28.07%
28.18%
Total Outstanding Shares
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
22,72,60,207
22,74,74,207
22,74,74,207
Total Shareholders
78,634
76,291
80,953
74,003
68,959
66,116
63,975
63,537
64,603
66,159
65,574
64,921
64,381

Mutual Funds that own Suven Life Sciences Stock

Check out the Mutual Funds with significant holdings in Suven Life Sciences.

Suven Life Sciences Corporate Actions

View detailed summary of the earnings and dividend history of Suven Life Sciences.

  • Suven Life Sciences Ltd Earnings Results

    Suven Life Sciences Ltd’s net profit fell -55.74% since last year same period to ₹-77.31Cr in the Q2 2025-2026. On a quarterly growth basis, Suven Life Sciences Ltd has generated -50.06% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Suven Life Sciences Ltd Dividends February,2019

    In the quarter ending December 2018, Suven Life Sciences Ltd has declared dividend of ₹1.50 per share on 05 Feb 2019 - translating a dividend yield of 1.12%.

    Read More about Dividends

Indices Featuring Suven Life Sciences Stock

Check stock indices that include Suven Life Sciences.

BSE Healthcare

₹41,313.49

-1.21 (▲504.50%)

BSE Small-Cap

₹46,825.31

-2.19 (▲1050.74%)

Insights on Suven Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.47 Cr → 4.7 Cr (in ₹), with an average increase of 47.5% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 28.07% to 28.18% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 148.1% return, outperforming this stock by 36.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 67.36% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 21.1% return, outperforming this stock by 10.3%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.18% to 1.07% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SUVEN stock has moved down by -10.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, -39.12 Cr → -77.31 Cr (in ₹), with an average decrease of 26.5% per quarter

About Suven Life Sciences Ltd

Suven Life Sciences Limited (erstwhile Suven Pharmaceuticals), established in 1989, is in the business of Contract Research and Manufacturing Services (CRAMS), providing process research and rapid response pilots scale 16 manufacture, custom synthesis, process R&D, and contract manufacturing of intermediates, APIs and formulations. It has two international wholly owned subsidiaries and one Indian wholly owned subsidiary. With the aim of expanding its drug discovery portfolio, a remarkable growth of 71% in total sales and a 325% growth in profit after tax (PAT) was registered during 2000-01. In addition, the company also acquired a pilot plant and got its recertification of ISO 9002 during the same year. In 2013-14, Suven granted an exclusive license to Taro Pharmaceuticals to market its product Head Lice Lotion in the US, Canada and Mexico, estimated at US$35million. During FY2014-15, one of its lead clinical candidates SUVN 502 has successfully completed the Phase 1b clinical trial, leading way for the entry into Proof of Concept (PoC) Phase 2a study. Thesaid year also saw the Company issuing and alloting 10, 453, 690 equity shares of Re 1/ each at a premium of Rs190.32 per share by way of QIP issue. In 2018-19, a Scheme of Arrangement for Demerger was initiated between Suven Life Sciences and Suven Pharmaceuticals Limited, resulting in a mirror shareholding of Suven Life Sciences in Suven Pharmaceuticals Limited. Consequently, Suven Pharmaceuticals Ltd., India and Suven Pharma Inc., USA became subsidiary companies of the group. As of 31st March 2019, investments were made to Suven Neurosciences Inc., a wholly owned subsidiary, amounting to Rs. 13, 636 lakh and no investments were made into newly formed Suven Pharma Inc., USA.

Revenue: ₹0.92Cr as on September 2025 (Q2 FY26)
Net Profit: ₹-77.31Cr as on September 2025 (Q2 FY26)
Listing date: 23 Oct, 2003
Chairperson Name: Venkateswarlu Jasti
OrganisationSuven Life Sciences Ltd
HeadquartersHyderabad
IndustryHealthcare
CEOVenkateswarlu Jasti
E-voting on sharesClick here to vote

FAQs

What is Suven Life Sciences share price today?

Suven Life Sciences share price today stands at ₹134.07 as on at the close of the market. Suven Life Sciences share today touched a day high of ₹138.69 and a low of ₹132.11.

What is the 52 week high and 52 week low range for Suven Life Sciences share?

Suven Life Sciences touched a 52 week high of ₹299.99 and a 52 week low of ₹102.5. Suven Life Sciences share price today i.e. is closed at ₹134.07, which is -55.31% down from its 52 week high and 30.80% up from its 52 week low.

What is Suven Life Sciences's market capitalisation today?

Suven Life Sciences market capitalisation is ₹3,049.75 Cr as on .

How to buy Suven Life Sciences shares?

To buy Suven Life Sciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUVEN or Suven Life Sciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Suven Life Sciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Suven Life Sciences trading volume today?

Suven Life Sciences trading volume is 2.48L as on . This means that 2.48L shares of Suven Life Sciences were bought and sold on the stock market during today's trading session.